IDO1 and neoplasm: Human lymphocytes reduced the tumor size (figure 5A-C, F, G); however, PD-L1/IDO-1 attacked TILs and attenuated this process under IFN-γ pathway activation in group C (PC3 tumor+T cells+IFN-γ; figure 5A-C, F, G).